Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.19.2
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Preferred Stock
Common Stock
Treasury Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Stockholders' equity, beginning balance at Dec. 31, 2017 $ 296,121   $ 500 $ 1,548 $ (170) $ 766,508 $ (468,753) $ (3,512)
Shares outstanding, beginning balance at Dec. 31, 2017 9,762              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Activity in employees’ stock plans $ (123)     3   (126)    
Activity in employees’ stock plans (in shares) 21              
Amortization of stock-based awards $ 979         979    
Predecessor preferred stock dividend (906)         (906)    
Comprehensive Income:                
Net income (loss) (28,796)           (28,796)  
Other comprehensive income (loss) (300)             (300)
Stockholders' equity, ending balance at Mar. 31, 2018 $ 266,975   500 1,551 (170) 766,455 (497,549) (3,812)
Shares outstanding, ending balance at Mar. 31, 2018 9,783              
Stockholders' equity, beginning balance at Dec. 31, 2017 $ 296,121   500 1,548 (170) 766,508 (468,753) (3,512)
Shares outstanding, beginning balance at Dec. 31, 2017 9,762              
Comprehensive Income:                
Net income (loss) $ (51,673)              
Other comprehensive income (loss) (2,547)              
Stockholders' equity, ending balance at Jun. 30, 2018 $ 241,730   500 1,557 (170) 766,328 (520,426) (6,059)
Shares outstanding, ending balance at Jun. 30, 2018 9,820              
Stockholders' equity, beginning balance at Mar. 31, 2018 $ 266,975   500 1,551 (170) 766,455 (497,549) (3,812)
Shares outstanding, beginning balance at Mar. 31, 2018 9,783              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Activity in employees’ stock plans $ (47)     6   (53)    
Activity in employees’ stock plans (in shares) 37              
Amortization of stock-based awards $ 833         833    
Predecessor preferred stock dividend (907)         (907)    
Comprehensive Income:                
Net income (loss) (22,877)           (22,877)  
Other comprehensive income (loss) (2,247)             (2,247)
Stockholders' equity, ending balance at Jun. 30, 2018 $ 241,730   500 1,557 (170) 766,328 (520,426) (6,059)
Shares outstanding, ending balance at Jun. 30, 2018 9,820              
Stockholders' equity, beginning balance at Dec. 31, 2018 $ 126,916   500 1,568 (170) 766,347 (634,450) (6,879)
Shares outstanding, beginning balance at Dec. 31, 2018 9,885              
Comprehensive Income:                
Net income (loss) $ (90,248)              
Other comprehensive income (loss) (377)              
Stockholders' equity, ending balance at Mar. 31, 2019 $ 342,800   0 150 0 342,650 0 0
Shares outstanding, ending balance at Mar. 31, 2019 15,044              
Stockholders' equity, beginning balance at Dec. 31, 2018 $ 126,916   500 1,568 (170) 766,347 (634,450) (6,879)
Shares outstanding, beginning balance at Dec. 31, 2018 9,885              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Activity in employees’ stock plans $ 0              
Amortization of stock-based awards 1,446         1,446    
Predecessor preferred stock dividend 0              
Comprehensive Income:                
Net income (loss) (90,248)           (90,248)  
Other comprehensive income (loss) (377)             (377)
Stockholders' equity, ending balance at Mar. 30, 2019 $ 37,737   500 1,568 (170) 767,793 (724,698) (7,256)
Shares outstanding, ending balance at Mar. 30, 2019 9,885              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuances of successor common stock $ 328,950     150   328,800    
Issuances of common stock (in shares)   15,044            
Comprehensive Income:                
Issuances of successor warrants 14,687         14,687    
Issuances of warrants (in shares)   0            
Equity issuance costs (837)         (837)    
Stockholders' equity, ending balance at Mar. 31, 2019 $ 342,800   0 150 0 342,650 0 0
Shares outstanding, ending balance at Mar. 31, 2019 15,044              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Amortization of stock-based awards $ 1,869         1,869    
Comprehensive Income:                
Net income (loss) 4,641           4,641  
Other comprehensive income (loss) (152)             (152)
Stockholders' equity, ending balance at Jun. 30, 2019 $ 349,158   $ 0 $ 150 $ 0 $ 344,519 $ 4,641 $ (152)
Shares outstanding, ending balance at Jun. 30, 2019 15,044